TY - GEN A1 - Pohl, Rainer A1 - Casperson, Ralf A1 - Ehlers, Henrik A1 - Pelkner, Matthias T1 - Elektromagnetische zerstörungsfreie Prüfverfahren N2 - Übersicht über die die im FB 8.4 bearbeiteten elektromagnetischen Prüfverfahren mit den Schwerpunkten bildgebende Wirbelstromprüfung, sensorbasierte Streuflussprüfung, magnetische Materialcharakterisierung und Sondenentwicklung. KW - Wirbelstromprüfung KW - Wirbelstromsenoren KW - GMR-Sensoren KW - Magnetische Materialcharakterisierung PY - 2020 SP - 1 PB - Bundesanstalt für Materialforschung und -prüfung (BAM) CY - Berlin AN - OPUS4-51033 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Maiwald, Michael T1 - On the way to the cyber-physical lab T1 - Auf dem Weg zum cyber-physical Lab N2 - Laboratories tend to be central hubs for chemical, biotechnological, pharmaceutical or foodstuff production. They play a key role in research and development, chemical analysis, quality assurance, maintenance and process control. For process development and optimization, process analytical technology (PAT) has proven to be a powerful tool to improve our understanding of processes, increase productivity, reduce waste and costs and shorten processing times. N2 - Im Allgemeinen sind Laboratorien zentrale Drehscheiben für die chemische, biotechnologische, pharmazeutische oder Lebensmittelproduktion. Sie spielen eine Schlüsselrolle in Forschung und Entwicklung, chemischer Analytik, Qualitätssicherung, Instandhaltung und Prozesskontrolle. Für die Prozessentwicklung und -Optimierung hat sich die Prozessanalysentechnik (PAT) als leistungsfähiges Werkzeug erwiesen, um das Prozessverständnis zu verbessern, die Produktivität zu steigern, Abfall und Kosten zu reduzieren und die Prozesszeit zu verkürzen. KW - Lab of the Future KW - Digitalisation KW - Cyber-physical Lab KW - Smart Laboratoy PY - 2020 SP - 1 EP - 3 PB - Lumitos AG CY - Darmstadt AN - OPUS4-51036 LA - mul AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Climent Terol, Estela T1 - Design and synthesis of lateral flow tests containing antibody-gated materials N2 - Methods for the rapid and sensitive detection of target analytes are gaining importance in medical diagnostics and environmental monitoring, in the security, occupational health and safety as well as food sectors. Among all the methods employed for rapid tests, lateral flow assays (LFAs) are the most commonly used. However, some drawbacks are that most of these tests either indicate the analyte only indirectly, and in other cases the sensitivity is not high enough. Keeping in mind these limitations, the use of stimuli-responsive materials for small-molecule sensing relying on chemical signal amplification and utilizing specific interactions between biomolecules such as antibodies and the corresponding analytes are particularly attractive. Such materials can also be incorporated on paper strips for lateral-flow assays in a straightforward manner. These sensing materials comprise mesoporous silica nanoparticles loaded with indicator molecules and containing certain hapten derivative molecules covalently grafted at the surface, which bind to the respective antibody and inhibit the release of a dye as reporter (Scheme 1). In presence of the designated analyte, a displacement of the antibody from the material is observed, allowing the release of dye. Because a large number of indicator molecules can be released when a single analyte molecule binds to an antibody cap, a strong signal amplification is observed. Considering the modularity, high sensitivity and selectivity of these antibody-gated indicator delivery systems, the presentation discusses general aspects of system design as well as analytical performance and highlights the integration into a lateral-flow assay, showing as an example the determination of the explosives TATP, TNT and PETN with a fluorescence readout, in single-substance and multiplexing modes. T2 - International Webinar on Biosensors and Bioelectronics CY - Online meeting DA - 20.07.2020 KW - Multiplexing detection KW - Rapid testing methods KW - Gated hybrid materials KW - Lateral flow tests KW - Explosives detection PY - 2020 UR - https://europeanmeetings.net/conferences/biosensor-bioelectronics AN - OPUS4-51038 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Silva, C. P. A1 - Carvalho, T. A1 - Schneider, Rudolf A1 - Esteves, V. I. A1 - Lima, D. L. D. T1 - ELISA as an effective tool to determine spatial and seasonal occurrence of emerging contaminants in the aquatic environment N2 - During the last two decades, studies related to the occurrence and fate of emerging contaminants in the aquatic environment have received great attention from the international scientific community. The monitoring of the presence of these compounds is particularly important since they are known to induce adverse effects in aquatic environments, even at extremely low concentrations. This work aimed to apply a simple and effective methodology, such as enzyme-linked immunosorbent assay (ELISA), in the monitoring of 17a-ethinylestradiol (EE2) and 17b-estradiol (E2) (a synthetic and a natural hormone, respectively), carbamazepine (CBZ, an antiepileptic), cetirizine (CET, an antihistamine) and caffeine (CAF, a stimulant) in water matrices with differing salinity and organic matter contents. ELISA was proven to be a valid and practical tool, especially for screening purposes in contrast to traditional chromatographic techniques which are prohibitively expensive for an application on a broader base. The main originality of this work was to establish seasonal and spatial effects on the occurrence of the referred contaminants by using the effectiveness of ELISA to screen those compounds in samples with different characteristics. This work reports both the seasonal and spatial quantification of the referred contaminants in the aquatic environment of the central region of Portugal, with concentrations ranging as follows: 5–87 ng L-1, for E2, 2–17 ng L-1, for EE2, 10–1290 ng L-1, for CBZ, 10–190 ng L-1, for CET, and 62–6400 ng L-1, for CAF. KW - Estrogen KW - Estradiol KW - Ethinylestradiol KW - Carbamazepine KW - Portugal KW - Wasser PY - 2020 DO - https://doi.org/10.1039/D0AY00426J SN - 1759-9679 VL - 12 IS - 19 SP - 2517 EP - 2526 PB - Royal Society of Chemistry RSC CY - London AN - OPUS4-51340 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Raysyan, Anna A1 - Eremin, S. A. A1 - Beloglazova, N. V. A1 - De Saeger, S. A1 - Gravel, I. V. T1 - Immunochemical approaches for detection of aflatoxin B1 in herbal medicines N2 - Introduction Aflatoxin B1 (AFB1) is a toxic low‐molecular‐weight secondary metabolite of Aspergillus flavus and A. parasiticus. AFB1 was classified as a Group I carcinogen by the World Health Organisation for Research on Cancer in 1993. AFB1 is an unavoidable natural contaminant of some herbal medicine, able to cause serious health issues for humans consuming the related medicine. Objective Therefore, this study aimed to develop an efficient fluorescence polarisation immunoassay (FPIA) and a rapid, low‐cost, and easy‐to‐use membrane‐based flow‐through immunoassay (MBA) for determination of AFB1 in herbal medicine Origanum vulgare L., Rubus idaeus L., Urtica dioica L. and Sorbus aucuparia L. Results A cut‐off level of the developed MBA was 0.8 ppb. Validation of the developed test was performed with blank and spiked samples. Using three naturally contaminated or three artificially spiked samples. The FPIA showed a linear working range of 8.6 to 64 ppb, and a half maximal inhibitory concentration (IC50) of 24 ppb. Conclusion The results were in good correlation with the enzymelinked immunosorbent assay (ELISA) results (the IC50 0.1 ppb). Both the sample preparation and analysis are simple, cost‐effective and easy to perform on‐site in non‐laboratory environments. Liquid chromatography with tandem mass spectrometry (LC‐MS/MS) was used as a confirmatory technique. KW - Fluorescence Polarisation Immunoassay KW - membrane-based flow-through immunoassay KW - Mycotoxins KW - Mykotoxine KW - Schnelltest PY - 2020 DO - https://doi.org/10.1002/pca.2931 SN - 1099-1565 VL - 31 IS - 5 SP - 662 EP - 669 PB - Wiley Online Libary CY - Hoboken, NJ, USA AN - OPUS4-51341 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Raysyan, Anna A1 - Galvidis, I. A. A1 - Schneider, Rudolf A1 - Eremin, S. A. A1 - Burkin, M. A. T1 - Development of a latex particles-based lateral flow immunoassay for group determination of macrolide antibiotics in breast milk N2 - A lateral flow immunoassay (LFIA) using latex particles labeled with antibody to BSAclarithromycin (CLA) was developed for the rapid simultaneous group determination of six macrolide antibiotics. Optimization of antigen spotting on the membrane and latex probe loading allowed improving visual detectability (vLOD) 100 times, which was 1, 1, 10, 10, 50, and 1000 ng/mL for CLA, roxithromycin, erythromycin, dirithromycin, azithromycin, and oleandomycin in buffer, respectively. The calculated limits of instrumental detection (cLOD) were respectively 0.12, 0.15, 1.4, 2.1, 2.4, and 3.3 ng/mL. To avoid a strong influence of breast milk of a very diverse and variable composition, a sample pretreatment is proposed. The six macrolides mentioned can be visually detected in breast milk after 20 minutes pretreatment at concentrations of 10-1000 ng / ml or instrumentally with cLOD of 4.0, 2.5, 30, 42, 42 and 180 ng/mL. The recovery rate from the spiked samples carried out using a strip scanner device ranged from 71% to 110%, and precision expressed as relative standard deviation was between 3-14%. The described rapid on-site diagnostic assay format can be useful for monitoring the content of antibiotics in breast milk during macrolide treatment to ensure safe breastfeeding of infants. KW - Clarithromycin KW - Roxithromycin KW - Erythromycin KW - Dirithromycin KW - Azithromycin KW - Oleandomycin KW - Macrolide antibiotics KW - Makrolide KW - Antibiotika PY - 2020 DO - https://doi.org/10.1016/j.jpba.2020.113450 SN - 0731-7085 VL - 189 IS - 113450 SP - 1 EP - 9 PB - Elsevier CY - Amsterdam, NL AN - OPUS4-51343 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Weise, Matthias T1 - Characterization of Surface Topometry and Determination of Layer Thickness by Scanning White Light Interference Microscopy N2 - 3D coherence scanning interferometry (CSI) is an optical, non-contact and rapide measurement technique using a defined bandwidth of white light at normal incidence. Based on this operational principle, white light interference microscopy (WLIM) provides three-dimensional surface topometry data up to a resolution of 0.4 μm lateral and 0.1 nm vertical. Three operating modi, i.e. surface, films and advanced films, enable measurements of step heights, roughness, wear volume, cone angle, surface pattern and layer thickness of transparent coatings. The determination of layer thickness by WLIM requires the knowledge of optical constants, i.e.the refractive index n and the extinction coefficient k. For technical surfaces, data base values - if available at all - have to be determined or validated by spectroscopic ellipsometry (SE). From this oblique incidence technique both optical constants and layer thickness can be derived based on a model for at least semi-transparent coatings. For different layer thicknesses, a comparison is made between WLIM and SE. Measurement uncertainty is discussed for both topometric features and layer thickness for different use cases. Traceability to SI system is ensured by certified standards (PTB/NIST) within a DAkkS DIN EN ISO/IEC 17025:2018 accredited lab. T2 - 17th International Conference on Plasma Surface Engineering (PSE) CY - Erfurt, Germany DA - 07.09.2020 KW - Rroughness and step heights KW - Lateral surface pattern KW - Layer thickness of transparent coatings KW - Scanning white light interferometry KW - Spectroscopic ellipsometry PY - 2020 AN - OPUS4-51301 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Denkler, Tilman T1 - EA-HHC - Analysis of the operation of accreditation bodies - Results of the 2nd round N2 - In 2019 the German federal institute Bundesanstalt für Materialforschung und –prüfung (BAM) conducted a benchmarking to compare the operations of European accreditation bodies and to identify best practices, with the aim of improving key processes in accreditation. Ten European accreditation bodies attended the comparison, four of which had already taken part in the pilot phase of the benchmarking project, which was conducted in 2017 by the German accreditation body Deutsche Akkreditierungsstelle GmbH (DAkkS) and the BAM. The study, designed to examine and compare the operation of accreditation bodies in Europe, used a management tool called Process Maturity Benchmarking Tool, which was especially elaborated and validated for this purpose in the pilot phase, in order to determine the values of indicators, thus enabling a comparison of the accreditation bodies despite different operational processes and organizational forms. The management tool is based on the analysis of selected processes with high relevance for the operation of accreditation bodies. The processes are derived from a process map designed for accreditation bodies in a universally applicable way. The indicators used to characterize the processes come from two sources: The first source relates to data already available from internal databases, reports, financial audits, and others. The second source is derived from the self-evaluation of process maturity performed by the accreditation bodies. The criteria for evaluating process maturities were designed by applying the criteria of the EFQM excellence model 2013 of the European Foundation for Quality Management (EFQM) to the processes identified in the process map. The results of the analysis were presented to and discussed with representatives of the ten accreditation bodies at a Results-Workshop that took place at BAM on 21/22 January 2020. In this presentation a wrap-up of the results was given to the HHC of EA T2 - Tagung des HHC (horizontal harmonization committee) der EA (European co-operation for accreditation) (virtuelles Meeting per MS-Teams, ca. 55 Teilnehmer) CY - Online meeting DA - 15.09.2020 KW - Accreditation KW - Benchmarking PY - 2020 AN - OPUS4-51251 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Klöckner, P. A1 - Seiwert, B. A1 - Eisentraut, Paul A1 - Braun, Ulrike A1 - Reemtsma, T. A1 - Wagner, S. T1 - Characterization of tire and road wear particles from road runoffindicates highly dynamic particle properties N2 - Tire and road wear particles (TRWPs) are heteroagglomerates of tire rubber and other particles deposited on the road surface and one of the main contributors to non-exhaust emissions of automobile traffic. In this study, samples from road environments were analyzed for their TRWP contents and concentra- tions of eight organic tire constituents. TRWP concentrations were determined by quantifying Zn in the density fraction < 1.9 g/cm ³and by thermal extraction desorption-gas chromatography-mass spectrometry (TED-GC/MS) and the concentrations ranged from 3.7 to 480 mg TRWP/g. Strong and statistically signif- icant correlations with TRWPs were found for 2-hydroxybenzothiazole and 2-aminobenzothiazole, indi- cating that these substances may be suitable markers of TRWPs. The mass distribution of TRWPs in road dust suggests that the main mass fraction formed on roads consists of coarse particles ( > 100 μm). Data for a sedimentation basin indicate that the fine fraction ( < 50 μm) is preferentially transported by road runoffinto receiving waters. The size distribution and density data of TRWP gathered by three different quantitation approaches also suggest that aging of TRWPs leads to changes in their particle density. An improved understanding of the dynamics of TRWP properties is essential to assess the distribution and dissipation of this contaminant of emerging concern in the environment. KW - Tire Wear KW - Density separation KW - Microplastic KW - Urban PY - 2020 DO - https://doi.org/10.1016/j.watres.2020.116262 VL - 185 SP - 116262 PB - Elsevier Ltd. AN - OPUS4-51256 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Becker, Roland T1 - Non-invasive cancer detection using volatile biomarkers: Is urine superior to breath? N2 - In recent years numerous reports have highlighted the options of chemical breath analysis with regard to noninvasive cancer detection. Certain volatile organic compounds (VOC) supposedly present in higher amounts or in characteristic patterns have been suggested as potential biomarkers. However, so far no clinical application based on a specific set of compounds appears to exist. Numerous reports on the capability of sniffer dogs and sensor arrays or electronic noses to distinguish breath of cancer patients and healthy controls supports the concept of genuine cancer-related volatile profiles. However, the actual compounds responsible for the scent are completely unknown and there is no correlation with the potential biomarkers suggested on basis of chemical trace analysis. It is outlined that specific features connected with the VOC analysis in breath – namely small concentrations of volatiles, interfering background concentrations, considerable sampling effort and sample instability, impracticability regarding routine application - stand in the way of substantial progress. The underlying chemicalanalytical challenge can only be met considering the severe susceptibility of VOC determination to these adverse conditions. Therefore, the attention is drawn to the needs for appropriate quality assurance/quality control as the most important feature for the reliable quantification of volatiles present in trace concentration. Consequently, the advantages of urine as an alternative matrix for volatile biomarker search in the context of diagnosing lung and other cancers are outlined with specific focus on quality assurance and practicability in clinical chemistry. The headspace over urine samples as the VOC source allows adapting gas chromatographical procedures well-established in water analysis. Foremost, the selection of urine over breath as non-invasive matrix should provide considerably more resilience to adverse effects during sampling and analysis. The most important advantage of urine over breath is seen in the option to partition, dispense, mix, spike, store, and thus to dispatch taylor-made urine samples on demand for quality control measures. Although it is still open at this point if cancer diagnosis supported by non-invasively sampled VOC profiles will ultimately reach clinical application the advantages of urine over breath should significantly facilitate urgently required steps beyond the current proof-of-concept stage and towards standardisation. KW - VOC KW - Breath KW - Urine KW - Lung cancer KW - Volatile organic compounds PY - 2020 DO - https://doi.org/10.1016/j.mehy.2020.110060 VL - 143 SP - 110060 PB - Elsevier Ltd. AN - OPUS4-51066 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -